KYA1797K, a tumor suppressor gene in colon cancer, inhibits PD-L1 N-glycosylation and suppresses immune evasion of colon CSCs through inhibition of the β-catenin/STT3 signaling pathway, opening up new possibilities for colon cancer immunotherapy [49]. Here, CD274 is linked to neoplasm.